Experts from the National Steering Committee for
COVID-19 Prevention and Control check a quarantine centre in the northern mountainous province of Lao Cai. (Photo: VNA)
Hanoi (VNA) - The COVID-19 pandemic has been well controlled in Vietnam,
but risks of an outbreak are still present, especially with the Tet (Lunar New Year) holiday
approaching, leading experts to warn that people need to strictly abide by
preventive regulations.
Associate
professor
Tran Dac Phu, senior advisor to the Vietnam Emergency Operations
Centre, told Ha Noi Moi (New Hanoi)
newspaper that the current risk of infection was mainly due to a lack of strict
Human trials of third homegrown COVID-19 vaccine to begin in March Chia sẻ | FaceBookTwitter Email Copy Link Copy link bài viết thành công
20/01/2021 14:45 GMT+7
A third COVID-19 vaccine developed by Vietnam is scheduled to be tested on humans at the end of March, the Ministry of Health said on January 19.
The highest dose, 75mcg, of Nanocovax was given to three volunteers in Hanoi on January 12. (Photo: MoH)
The vaccine is developed by Vaccine and Biological Production No. 1 (VABIOTECH). It is one of the four companies that are developing COVID-19 vaccines in Vietnam, along with the Institute of Vaccines and Medical Biologicals (IVAC), the Centre for Research and Production of Vaccines and Biologicals (POLYVAC), and Nanogen Pharmaceutical Biotechnology (NANOGEN).
email article
Two small trials added to the evidence that some stroke patients could fare well going straight to mechanical thrombectomy without IV thrombolysis, though the studies were confined to Asian populations and non-inferiority was not shown in the strictest sense.
For patients with acute ischemic stroke due to large vessel occlusion, results were inconclusive (but somewhat favorable) for a strategy of skipping the IV tissue plasminogen activator (tPA) usually recommended prior to mechanical thrombectomy in the Japanese SKIP trial.
However, a similar strategy did prove to be non-inferior to combined thrombectomy and IV tPA in the Chinese DEVT trial.
Volunteers receive second shots of Nanocovax vaccine 16:38 | 20/01/2021
At the Military Medical University (Photo: VNA)
Hanoi â Twenty volunteers received the second shots of Nanocovax - a Vietnam-developed COVID-19 vaccine at the Military Medical University on January 20.
Among them, three people, who had been injected a dose on December 26, 2020, were given a dose of 50mcg and the remainders got a dose of 25 mcg. All of the volunteers are now in stable conditions.
Vietnam has so far gone through more than half of the first stage of clinical vaccine trials.
Associate Prof. Ho Anh Son, Deputy Director of the Military Medical Universityâs Institute of Biomedicine and Pharmacy,said the test results 7,14 and 28 days after the injection showed that the vaccine is capable of producing immunity and ensuring safety.
VIETNAM NEWS JANUARY 17
17/01/2021 08:10 GMT+7
National medical council makes debut
The national medical council officially made its debut at a ceremony in Hanoi on January 15.
The national medical council officially made its debut at a ceremony in Hanoi on January 15, which has been regarded as a milestone of the domestic health care sector.
The council was formed in line with the Prime Minister’s Decision No. 956/QD-TTg, with the aim of assisting the Government leader in preparing necessary conditions for organising capacity assessment in medical profession.
The establishment of the council is in accordance with international commitments on medical capacity standards and matches Vietnam’s situation, Deputy Prime Minister Vu Duc Dam said, urging the council to soon put forth its operation regulations as well as mechanisms for the organisation of medical licensing examinations.